Cargando…

Susceptibility‐guided sequential strategy versus empirical therapy for Helicobacter pylori infection: study protocol for a randomised controlled trial

BACKGROUND: New treatment strategies are required against infections caused by Helicobacter pylori, which grows increasingly resistant to antibiotics. Polymerase chain reaction-based methods for antibiotic susceptibility testing are available for detecting H. pylori-specific mutations that confer re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Kemei, Lang, Cuicui, Zou, Xuefei, Zang, Lina, Sang, WeiWei, Feng, Qian, Mu, Ying, Liu, Lifeng, Xu, Chunhong, Zhao, Jingrun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278287/ https://www.ncbi.nlm.nih.gov/pubmed/37337241 http://dx.doi.org/10.1186/s13063-023-07457-z

Ejemplares similares

Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review
por: Gisbert, Javier P.
Publicado: (2020)

Optimizing Helicobacter pylori Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments
por: Ishibashi, Fumiaki, et al.
Publicado: (2023)

Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis
por: Nyssen, Olga P., et al.
Publicado: (2022)

Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy
por: Liou, Jyh-Ming, et al.
Publicado: (2022)

Increased susceptibility to Helicobacter pylori infection in pregnancy.
por: Lanciers, S, et al.
Publicado: (1999)

“Concomitant” or “sequential” eradication of Helicobacter pylori: which regimen comes first?
por: Georgopoulos, Sotirios D.
Publicado: (2014)

Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pylori
por: Tamene, Yonas, et al.
Publicado: (2023)

Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis
por: Kim, Joon Sung, et al.
Publicado: (2013)

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
por: Chang, Ji Young, et al.
Publicado: (2017)

Helicobacter pylori infection is an infectious disease and the empiric therapy paradigm should be changed
por: Li, Hong, et al.
Publicado: (2019)

Considering the Long-Conflicting Topic of Empirical or Nonconventional Helicobacter pylori Eradication Regimens
por: Kountouras, Jannis
Publicado: (2023)

Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines
por: Destura, Raul V, et al.
Publicado: (2004)

Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in Northeastern Ontario
por: Eng, Nelson F, et al.
Publicado: (2015)

The impact of host's genetic susceptibility on Helicobacter pylori infection in children
por: Mărginean, Maria Oana, et al.
Publicado: (2017)

Susceptibility-guided therapy for Helicobacter pylori infection treatment failures
por: Yu, Lou, et al.
Publicado: (2019)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

Evaluation of Susceptibility of the Human Pathogen Helicobacter pylori to the Antibiotic Capreomycin
por: Sukati, Suriyan, et al.
Publicado: (2022)

Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection
por: Ng, Ho-Yu, et al.
Publicado: (2023)

Do Probiotics Improve Eradication Response to Helicobacter Pylori on Standard Triple or Sequential Therapy?
por: Dajani, Asad I., et al.
Publicado: (2013)

Sequential Therapy vs Quadruple Therapy for Helicobacter pylori Eradication in South West of Iran
por: Masjedizadeh, Abdol Rahim, et al.
Publicado: (2014)

Helicobacter pylori
por: Harris, A. W. (Adam W.), 1963-
Publicado: (1996)

Helicobacter Pylori
por: Aguilar Lasserre, Rubén
Publicado: (1998)

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
por: Liou, Jyh-Ming, et al.
Publicado: (2016)

Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates
por: Godoy, Anita Paula Ortiz, et al.
Publicado: (2003)

Antimicrobial susceptibility of Helicobacter pylori isolates from Lower Silesia, Poland
por: Biernat, Monika Maria, et al.
Publicado: (2013)

Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection
por: Mascellino, Maria Teresa, et al.
Publicado: (2017)

Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection
por: Arslan, Nazlı, et al.
Publicado: (2017)

Susceptibility-guided bismuth quadruple therapies for resistant Helicobacter pylori infections
por: Yang, Tiankuo, et al.
Publicado: (2020)

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
por: Gatta, Luigi, et al.
Publicado: (2013)

Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
por: Jung, Sung Min, et al.
Publicado: (2016)

Hybrid Therapy versus Sequential Therapy for Eradication of Helicobacter pylori: A Randomized Controlled Trial
por: Ashokkumar, Sahoo, et al.
Publicado: (2017)

The cost-effectiveness of sequential versus standard triple therapy for Helicobacter pylori eradication in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Randomized Clinical Trial on the Efficacy of Triple Therapy Versus Sequential Therapy in Helicobacter pylori Eradication
por: Sharif, Zain, et al.
Publicado: (2022)

Treatment of Pediatric Helicobacter pylori Infection
por: Lai, Hung-Hsiang, et al.
Publicado: (2022)

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2016)

Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation
por: Yang, Ji Yeong, et al.
Publicado: (2021)

Regulation of p53 by Helicobacter pylori
por: Zaika, Alexander, et al.
Publicado: (2012)

Susceptibility-guided vs. empirical 10-day quadruple treatment for Helicobacter pylori-infected patients: A prospective clinical trial of first-line therapy
por: Li, Peiwei, et al.
Publicado: (2022)

Helicobacter pylori : revisión bibliográfica
por: Gómez Morayta, Enrique
Publicado: (2003)

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy
por: Chiu, Yu‐Tse, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_icq7iehqu2kd80ov65vpvjivfv